RecallDepth
Class II Completed

Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
April 25, 2022
Posted
May 4, 2022
Recall Number
D-0792-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,003 bottles
Firm Location
Mahwah, NJ, United States

Reason for Recall

cGMP deviations

Distribution

USA nationwide

Lot / Code Info

Lot #: 29200064, Exp 5/31/2023

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls